Risultati della ricerca - Timothy C Thompson

DNA Damage Response Inhibitor and Anti-PD-L1 Therapy for Prostate Cancer: Development of Predictive Biomarkers di Chuandong Geng, Timothy C. Thompson

Testo

Connecting androgen receptor signaling and the DNA damage response: Development of new therapies for advanced prostate cancer di Timothy C. Thompson, Likun Li

Testo

Identification of a novel prostate cancer biomarker, caveolin-1: Implications and potential clinical benefit di Paul G Corn, Timothy C Thompson

Testo

Cytopathic effects and local immune responses in repeated neoadjuvant HSV-tk + ganciclovir gene therapy for prostate cancer di Nobuyuki Yanagisawa, Takefumi Satoh, Ken-ichi Tabata, Hideyasu Tsumura, Yasutomo Nasu, Masami Watanabe, Timothy C. Thompson, Isao Okayasu, Yoshiki Murakumo, Shiro Baba, Masatsugu Iwamura

Testo

Validation of a prognostic blood-based sphingolipid panel for men with localized prostate cancer followed on active surveillance di Justin R. Gregg, Lisa Newcomb, Ranran Wu, Jennifer Dennison, John W. Davis, Curtis Pettaway, Louis Pisters, John F. Ward, Brian F. Chapin, Lisly Chéry, Ahmet Urkmez, Andrew M. Fang, Noel Higgason, Patricia Troncoso, Carrie R. Daniel, Christopher Logothetis, Timothy C. Thompson, Andrew W. Hahn, Menghan Liu, Yingye Zheng, Dan W. Lin, Samir Hanash, Ehsan Irajizad, Johannes Fahrmann

Testo

Targeting arginine metabolism overcomes chemotherapy resistance in aggressive-variant prostate cancers di Elavarasan Subramani, Patrick G. Pilié, Rebecca Slack-Tidwell, Paul V. Viscuse, Xianghong Kuang, Thirukumaran Kandasamy, Dominik Awad, Jenny J. Han, Licai Huang, Christine B. Peterson, Amado J. Zurita, Sumit K. Subudhi, Paul G. Corn, Rama Soundararajan, Peter Shepherd, Badrajee Piyarathna, Vasanta Putluri, Nagireddy Putluri, Arun Sreekumar, Yuzhuo Wang, Amina Zoubeidi, Iqbal Mahmud, Sara A. Martinez, Lin Tan, Philip L. Lorenzi, Sreyashi Basu, Sonali Jindal, Padmanee Sharma, Christopher J. Logothetis, Timothy C. Thompson, Daniel E. Frigo, Ana M. Aparicio

Testo